

Active ingredients | Message type | Date of the last message | Type of reason |
Moxifloxacin hydrochloride (Ph.Eur.) ((with details of water content (1:x))) | Initial notification | 16.05.2025 | Other |
Levomethadone hydrochloride | Change notification | 16.05.2025 | Other |
Sodium mucophenolate | Change notification | 16.05.2025 | Other |
Hydromorphone hydrochloride | Change notification | 16.05.2025 | Other |
Arsenic(III) oxide | Initial notification | 16.05.2025 | Other |
Sodium (methylprednisolone-21-succinate) | Initial notification | 16.05.2025 | Other |
Moxifloxacin hydrochloride (Ph.Eur.) ((with details of water content (1:x))) | Change notification | 15.05.2025 | Production problem |
Insulin aspart | Initial notification | 15.05.2025 | Other |
Salbutamol sulfate | Change notification | 15.05.2025 | Other |
Methylphenidate hydrochloride | Change notification | 15.05.2025 | Other |
Aprepitant | Change notification | 15.05.2025 | Other |
Quetiapine fumarate (Ph.Eur.) | Change notification | 15.05.2025 | Other |
Sertraline hydrochloride | Initial notification | 15.05.2025 | Production problem |
Flupentixol decanoate | Change notification | 15.05.2025 | Production problem |
Aprepitant | Initial notification | 14.05.2025 | Other |
Epinephrine/adrenaline | Change notification | 14.05.2025 | Production problem |
Erythromycin | Change notification | 14.05.2025 | Other |
Trazodone hydrochloride | Initial notification | 14.05.2025 | Other |
Tenofovir disoproxil | Change notification | 14.05.2025 | Other |
Ezetimibe; Simvastatin | Initial notification | 14.05.2025 | Production problem |
Methylphenidate hydrochloride | Initial notification | 14.05.2025 | Production problem |
Zoledronic acid monohydrate | Change notification | 14.05.2025 | Production problem |
Cyclophosphamide monohydrate | Change notification | 14.05.2025 | Other |
Zoledronic acid monohydrate | Change notification | 14.05.2025 | Production problem |
Metformin hydrochloride; sitagliptin hydrochloride monohydrate | Change notification | 14.05.2025 | Other |
Morphine hemisulfate 2,5-hydrate | Initial notification | 13.05.2025 | Other |
Sodium (methylprednisolone-21-succinate) | Initial notification | 13.05.2025 | Other |
Prednisolone | Initial notification | 13.05.2025 | Production problem |
Lorazepam | Initial notification | 13.05.2025 | Other |
Mometasone furoate (Ph.Eur.) | Change notification | 12.05.2025 | Production problem |
Tropicamide | Change notification | 12.05.2025 | Production problem |
Rizatriptan benzoate | Change notification | 12.05.2025 | Production problem |
Ezetimibe | Change notification | 12.05.2025 | Production problem |
Atomoxetine hydrochloride | Change notification | 12.05.2025 | Production problem |
Cyclopentolate hydrochloride | Change notification | 12.05.2025 | Production problem |
Atorvastatin calcium trihydrate (Ph.Eur.) | Change notification | 12.05.2025 | Other |
Ciclopirox-Olamin | Change notification | 12.05.2025 | Other |
Mometasone furoate (Ph.Eur.) | Change notification | 12.05.2025 | Other |
Ingredients | Status | Update | Specialty |
Immunoglobulin normal human (IgG) | Supply tension | 15/05/2025 | Immunoglobulin normal human IV and SC (based on) – |
methylphenidate (hydrochloride) | Available for use | 15/05/2025 | Methylphenidate Arrow LP, sustained-release capsule – |
disopyramide (phosphate) | Out of stock | 15/05/2025 | Rythmodan 250 mg sustained-release, coated tablet – |
levodopa – carbidopa | Available for use | 15/05/2025 | Sinemet 250 mg/25 mg, scored tablet – |
levomepromazine | Available for use | 15/05/2025 | Nozinan 100 mg, scored film-coated tablet – |
peginterferon alfa-2a | Supply tension | 14/05/2025 | Pegasys 90 micrograms, 135 micrograms and 180 micrograms solution for injection in pre-filled syringe – |
venlafaxine | Supply tension | 13/05/2025 | Venlafaxine Viatris 50 mg, film-coated tablet – |
liothyronine sodium | Supply tension | 13/05/2025 | Cynomel 0.025 mg, comprimé sécable- |
methylphenidate (hydrochloride) | Out of stock | 13/05/2025 | Methylphenidate EG LP 18 mg and 54 mg, extended-release tablet – |
(tranexamic acid | Supply tension | 13/05/2025 | Exacyl 500 mg, film-coated tablet – ) |
colchicine, opium (powder), tiemonium (metilsulfate) | Supply tension | 13/05/2025 | Colchimax, scored film-coated tablet and Colchicine Opocalcium 1 mg, scored tablet – |
hydroxocobalamin | Supply tension | 12/05/2025 | Cyanokit 5 g, powder for solution for infusion – |
amiodarone | Supply tension | 12/05/2025 | Cordarone 150 mg/3 ml, solution for injection in ampoule (IV) – |
Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
fentanyl | Drug delivery system, transdermal | 4.2 mg | Discontinued | Unavailable | Manufacturing | 16/05/2025 |
fentanyl | Drug delivery system, transdermal | 8.4 mg | Discontinued | Unavailable | Manufacturing | 16/05/2025 |
fentanyl | Drug delivery system, transdermal | 12.6 mg | Discontinued | Unavailable | Manufacturing | 16/05/2025 |
fentanyl | Drug delivery system, transdermal | 16.8 mg | Discontinued | Unavailable | Manufacturing | 16/05/2025 |
fentanyl | Drug delivery system, transdermal | 2.1 mg | Discontinued | Unavailable | Manufacturing | 16/05/2025 |
calcitonin salmon | Injection, solution | 100 IU/mL | Current | Limited Availability | Commercial Changes / Commercial viability | 16/05/2025 |
furosemide | Injection, solution | 20 mg | Resolved | Available | Manufacturing | 16/05/2025 |
silver sulfadiazine | Cream | 10 mg/g | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 16/05/2025 |
silver sulfadiazine | Cream | 10 mg/g | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 16/05/2025 |
fentanyl | Drug delivery system, transdermal | 5.1 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 16/05/2025 |
fentanyl | Drug delivery system, transdermal | 7.65 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 16/05/2025 |
fentanyl | Drug delivery system, transdermal | 1.28 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 16/05/2025 |
fentanyl | Drug delivery system, transdermal | 10.2 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 16/05/2025 |
fentanyl | Drug delivery system, transdermal | 2.55 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 16/05/2025 |
carboplatin | Injection, solution | 450 mg | Anticipated | Available | Manufacturing | 16/05/2025 |
dulaglutide | Injection, solution | 1.5 mg | Current | Limited Availability | Manufacturing | 16/05/2025 |
busulfan | Injection, concentrated | 60 mg | Current | Limited Availability | Manufacturing | 16/05/2025 |
isavuconazonium sulfate | Capsule, hard | 186.3 mg | Resolved | Available | Manufacturing | 16/05/2025 |
buprenorphine hydrochloride | Tablet, uncoated | .216 mg | Anticipated | Available | Manufacturing | 16/05/2025 |
lidocaine hydrochloride | Injection, solution | 10 mg/mL | Current | Unavailable | Manufacturing | 16/05/2025 |
paclitaxel | Injection, concentrated | 6 mg/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 16/05/2025 |
iopromide | Injection, solution | 498.72 mg/mL | Resolved | Available | Manufacturing | 16/05/2025 |
voriconazole | Tablet, film coated | 50 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 16/05/2025 |
sertraline hydrochloride | Tablet, film coated | 112 mg | Anticipated | Available | Manufacturing | 16/05/2025 |
ceftazidime pentahydrate | Injection, powder for | 2.328 g | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 15/05/2025 |
sumatriptan succinate | Tablet, film coated | 140 mg | Resolved | Available | Manufacturing | 15/05/2025 |
bethanechol chloride | Tablet, uncoated | 10 mg | Anticipated | Available | Manufacturing | 15/05/2025 |
galantamine hydrobromide | Capsule, modified release | 20.512 mg | Current | Limited Availability | Manufacturing | 15/05/2025 |
methylphenidate hydrochloride | Capsule, modified release | 10 mg | Current | Limited Availability | Manufacturing | 15/05/2025 |
valsartan~hydrochlorothiazide | Tablet, film coated | 160 mg~12.5 mg | Current | Limited Availability | Manufacturing | 15/05/2025 |
amlodipine besilate~atorvastatin calcium trihydrate | Tablet, film coated | 6.94 mg~43.376 mg | Anticipated | Available | Manufacturing | 15/05/2025 |
rosuvastatin calcium~ezetimibe | Tablet~Tablet, film coated | 10.396 mg~10 mg | Resolved | Available | Manufacturing | 15/05/2025 |
imatinib mesilate | Capsule, hard | 119.47 mg | Resolved | Available | Manufacturing | 15/05/2025 |
mercaptopurine monohydrate | Tablet | 50 mg | Current | Limited Availability | Manufacturing | 15/05/2025 |
topotecan hydrochloride | Injection, concentrated | 4.346 mg | Resolved | Available | Manufacturing | 15/05/2025 |
irinotecan hydrochloride trihydrate | Injection, concentrated | 500 mg | Resolved | Available | Manufacturing | 15/05/2025 |
metoprolol tartrate | Tablet, uncoated | 50 mg | Current | Limited Availability | Manufacturing | 15/05/2025 |
foscarnet sodium | Injection, solution | 24 mg/mL | Current | Limited Availability | Manufacturing | 15/05/2025 |
bleomycin sulfate | Injection, powder for | 15000 IU | Anticipated | Available | Manufacturing | 15/05/2025 |
trandolapril | Capsule, hard | 2 mg | Anticipated | Available | Manufacturing | 15/05/2025 |
losartan potassium | Tablet, film coated | 50 mg | Current | Limited Availability | Unexpected increase in consumer demand | 15/05/2025 |
voriconazole | Injection, powder for | 200 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 15/05/2025 |
sertraline hydrochloride | Tablet, film coated | 56 mg | Anticipated | Available | Manufacturing | 15/05/2025 |
Mumps virus~Rubella virus~Measles virus | Injection, powder for | 5000 CCID50~1000 CCID50~1000 CCID50 | Anticipated | Available | Unexpected increase in consumer demand | 15/05/2025 |
fentanyl | Drug delivery system, transdermal | 16.8 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 14/05/2025 |
honey bee venom | Injection, powder for | 550 microgram | Current | Limited Availability | Manufacturing | 14/05/2025 |
perindopril erbumine | Tablet | 8 mg | Current | Limited Availability | Manufacturing | 14/05/2025 |
Paper wasp venom | Injection, powder for | 550 microgram | Current | Unavailable | Manufacturing | 14/05/2025 |
lansoprazole | Tablet, orally disintegrating | 15 mg | Current | Limited Availability | Manufacturing | 14/05/2025 |
celecoxib | Capsule, hard | 200 mg | Current | Limited Availability | Manufacturing | 14/05/2025 |
entecavir | Tablet, film coated | .5 mg | Current | Unavailable | Manufacturing | 14/05/2025 |
cisatracurium besilate | Injection, solution | 14.07 mg | Current | Limited Availability | Manufacturing | 14/05/2025 |
procarbazine hydrochloride | Capsule, hard | 58.3 mg | Resolved | Available | Manufacturing | 14/05/2025 |
atomoxetine hydrochloride | Capsule, hard | 91.44 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 14/05/2025 |
olanzapine | Tablet, uncoated | 5 mg | Resolved | Available | Manufacturing | 14/05/2025 |
dosulepin hydrochloride | Capsule, hard | 25 mg | Resolved | Available | Manufacturing | 14/05/2025 |
methylphenidate hydrochloride | Capsule, hard | 40 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 14/05/2025 |
methylphenidate hydrochloride | Capsule, hard | 30 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 14/05/2025 |
methylphenidate hydrochloride | Capsule, hard | 10 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 14/05/2025 |
fentanyl citrate | Injection, solution | 785 microgram | Current | Limited Availability | Manufacturing | 14/05/2025 |
tamoxifen citrate | Tablet, uncoated | 15.2 mg | Current | Unavailable | Manufacturing | 14/05/2025 |
tamoxifen citrate | Tablet, uncoated | 30.4 mg | Current | Limited Availability | Manufacturing | 14/05/2025 |
gemfibrozil | Tablet, film coated | 600 mg | Current | Unavailable | Manufacturing | 14/05/2025 |
mirtazapine | Tablet, film coated | 30 mg | Resolved | Available | Manufacturing | 14/05/2025 |
trimethoprim~sulfamethoxazole | Tablet | 160 mg~800 mg | Resolved | Available | Unexpected increase in consumer demand | 13/05/2025 |
pramipexole dihydrochloride monohydrate | Tablet | .25 mg | Anticipated | Available | Manufacturing | 13/05/2025 |
phenobarbital sodium | Injection, solution | 219 mg/mL | Anticipated | Available | Manufacturing | 13/05/2025 |
galantamine hydrobromide | Capsule, modified release | 10.252 mg | Current | Unavailable | Manufacturing | 13/05/2025 |
galantamine hydrobromide | Capsule, modified release | 20.504 mg | Current | Unavailable | Manufacturing | 13/05/2025 |
ondansetron | Tablet, orally disintegrating | 8 mg | Current | Unavailable | Manufacturing | 13/05/2025 |
raloxifene hydrochloride | Tablet, film coated | 60 mg | Resolved | Available | Unexpected increase in consumer demand | 13/05/2025 |
dutasteride | Capsule, soft | 500 microgram | Current | Limited Availability | Manufacturing | 13/05/2025 |
capecitabine | Tablet, film coated | 500 mg | Current | Limited Availability | Unexpected increase in consumer demand | 13/05/2025 |
methotrexate | Injection, solution | 100 mg/mL | Current | Unavailable | Manufacturing | 13/05/2025 |
pramipexole dihydrochloride monohydrate | Tablet, modified release | .375 mg | Current | Limited Availability | Manufacturing | 13/05/2025 |
linezolid | Tablet, film coated | 600 mg | Current | Unavailable | Manufacturing | 13/05/2025 |
irbesartan | Tablet, film coated | 300 mg | Anticipated | Available | Manufacturing | 13/05/2025 |
irbesartan | Tablet, film coated | 150 mg | Anticipated | Available | Manufacturing | 13/05/2025 |
nizatidine | Capsule, hard | 150 mg | Current | Unavailable | Manufacturing | 13/05/2025 |
moxonidine | Tablet, film coated | 200 microgram | Current | Limited Availability | Manufacturing | 13/05/2025 |
ropinirole hydrochloride | Tablet, film coated | .57 mg | Resolved | Available | Manufacturing | 13/05/2025 |
risperidone | Tablet, film coated | 3 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 13/05/2025 |
atorvastatin calcium trihydrate~ezetimibe | Tablet, film coated | 41.363 mg~10 mg | Current | Unavailable | Manufacturing | 13/05/2025 |
suxamethonium chloride dihydrate | Injection, solution | 100 mg | Anticipated | Available | Manufacturing | 13/05/2025 |
methotrexate | Tablet | 10 mg | Resolved | Available | Manufacturing | 13/05/2025 |
azithromycin dihydrate | Tablet, film coated | 524 mg | Current | Unavailable | Unexpected increase in consumer demand | 13/05/2025 |
rivaroxaban | Tablet, film coated | 20 mg | Current | Limited Availability | Manufacturing | 13/05/2025 |
metoclopramide hydrochloride monohydrate | Injection, solution | 10.54 mg | Anticipated | Available | Unexpected increase in consumer demand | 13/05/2025 |
midazolam | Injection, solution | 5 mg/mL | Current | Limited Availability | Unexpected increase in consumer demand | 13/05/2025 |
Teriparatide | Injection, solution | 250 microgram | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 13/05/2025 |
metformin hydrochloride | Tablet, film coated | 1000 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 13/05/2025 |
Peginterferon alfa2a | Injection, solution | 180 microgram | Current | Limited Availability | Unexpected increase in consumer demand | 13/05/2025 |
heparin sodium | Injection, solution | 5000 IU/mL | Resolved | Available | Unexpected increase in consumer demand | 12/05/2025 |
exemestane | Tablet, film coated | 25 mg | Current | Unavailable | Manufacturing | 12/05/2025 |
aripiprazole | Tablet, uncoated | 10 mg | Current | Limited Availability | Manufacturing | 12/05/2025 |
sulfamethoxazole~trimethoprim | Tablet, uncoated | 800 mg~160 mg | Current | Limited Availability | Manufacturing | 12/05/2025 |
montelukast sodium | Tablet, chewable | 4.16 mg | Anticipated | Available | Manufacturing | 12/05/2025 |
quetiapine fumarate | Tablet, modified release | 57.565 mg | Current | Unavailable | Unexpected increase in consumer demand | 12/05/2025 |
zolmitriptan | Tablet, film coated | 2.5 mg | Current | Unavailable | Manufacturing | 12/05/2025 |
zolmitriptan | Tablet, film coated | 2.5 mg | Current | Unavailable | Manufacturing | 12/05/2025 |
adrenaline (epinephrine) acid tartrate | Injection, solution | 182 microgram/mL | Current | Unavailable | Manufacturing | 12/05/2025 |
estradiol~dydrogesterone | Tablet, film coated | 1 mg~10 mg | Resolved | Available | Manufacturing | 12/05/2025 |
ezetimibe | Tablet, uncoated | 10 mg | Resolved | Available | Manufacturing | 12/05/2025 |
olmesartan medoxomil~hydrochlorothiazide | Tablet | 40 mg~25 mg | Resolved | Available | Manufacturing | 12/05/2025 |
acamprosate calcium | Tablet, enteric coated | 333 mg | Current | Limited Availability | Manufacturing | 12/05/2025 |
avibactam sodium~ceftazidime pentahydrate | Injection, powder for | 543.5 mg~2329.7 mg | Current | Limited Availability | Unexpected increase in consumer demand | 12/05/2025 |
sitagliptin hydrochloride monohydrate | Tablet, film coated | 54.5 mg | Resolved | Available | Manufacturing | 12/05/2025 |